Implant Reclassification Required In Many Cases, EU Regulators Agree

Vigilance data collected by the Swedish National Board of Health and Welfare show that adverse events are linked to device design problems twice as often as manufacturing problems, the board's device official Bo Hojdefors, reported March 27 at an IBC regulatory conference in London.

More from Archive

More from Medtech Insight